In developing countries where new immunohistochemical stains such as immunostain Glut1 has limited availability, it is common to see vascular malformations which have ‘failed’ inappropriate treatment with steroids and/or propranolol, a practice which can be traced back to the continued inappropriate use of the term ‘hemangioma’ by pathologists. This evidence concerns the gene SLC2A1 and vascular malformation.